Anzeige
Mehr »
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QB4J | ISIN: US82686Q1013 | Ticker-Symbol: XRP2
Tradegate
21.11.24
19:42 Uhr
7,250 Euro
+0,700
+10,69 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
SILENCE THERAPEUTICS PLC ADR Chart 1 Jahr
5-Tage-Chart
SILENCE THERAPEUTICS PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
7,2007,50020:18

Aktuelle News zur SILENCE THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiSilence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst11
MoSilence Therapeutics plc: Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting308New zerlasiran data show significant time-averaged Lp(a) reductions with effects persisting 60 weeks following the first dose Represents first study to report time-averaged Lp(a) results to further...
► Artikel lesen
FrAnalyst Scoreboard: 4 Ratings For Silence Therapeutics2
14.11.Silence Therapeutics reports Q3 results2
14.11.Silence Therapeutics plc - 6-K, Report of foreign issuer1
14.11.Silence Therapeutics plc: Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights261Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), a global clinical stage biotechnology company committed to transforming people's lives by silencing diseases through precision engineered...
► Artikel lesen
14.11.Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights75LONDON--(BUSINESS WIRE)--Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), a global clinical stage biotechnology company committed to transforming people's lives by silencing...
► Artikel lesen
13.11.Silence Therapeutics plc: Silence Therapeutics to Participate in Fireside Chat at the Jefferies London Healthcare Conference149Silence Therapeutics plc, Nasdaq: SLN ("Silence" or the "Company"), a global clinical stage biotechnology company committed to transforming people's lives by silencing diseases through precision engineered...
► Artikel lesen
SILENCE THERAPEUTICS Aktie jetzt für 0€ handeln
08.10.Morgan Stanley Reaffirms Overweight Rating for Silence Therapeutics (NASDAQ:SLN)12
02.09.Silence Therapeutics shares start at Buy from Jefferies, reflecting strong clinical data4
30.08.H.C. Wainwright reiterates Buy on Silence Therapeutics stock amid strong trial results1
27.08.Silence Therapeutics plc: Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences200Silence Therapeutics plc, Nasdaq: SLN ("Silence" or the "Company"), an experienced and innovative biotechnology company committed to transforming people's lives by silencing diseases through precision...
► Artikel lesen
16.08.Silence Therapeutics stock holds top pick spot and outperform rating at BMO1
16.08.Analyst Expectations For Silence Therapeutics' Future2
16.08.Silence Therapeutics reports Q2 results2
15.08.Silence Therapeutics plc - 6-K, Report of foreign issuer1
15.08.Silence Therapeutics plc: Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights607Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company committed to transforming people's lives by silencing diseases through precision...
► Artikel lesen
15.08.Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights163LONDON--(BUSINESS WIRE)--Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company committed to transforming people's lives by silencing...
► Artikel lesen
27.06.Silence Therapeutics plc - 6-K, Report of foreign issuer1
24.06.Silence Therapeutics Receives $2M Milestone Payment from Hansoh3
Seite:  Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1